Santosh J. Vetticaden
2013 - Mast Therapeutics
In 2013, Santosh J. Vetticaden earned a total compensation of $522.3K as Former Chief Medical Officer and Senior Vice President at Mast Therapeutics, a 17% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $104,891 |
|---|---|
| Option Awards | $50,313 |
| Salary | $350,000 |
| Other | $17,094 |
| Total | $522,298 |
Vetticaden received $350K in salary, accounting for 67% of the total pay in 2013.
Vetticaden also received $104.9K in non-equity incentive plan, $50.3K in option awards and $17.1K in other compensation.
Rankings
In 2013, Santosh J. Vetticaden's compensation ranked 9,217th out of 12,286 executives tracked by ExecPay. In other words, Vetticaden earned more than 25.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,217 out of 12,286 | 25th |
Division Manufacturing | 3,370 out of 4,612 | 27th |
Major group Chemicals And Allied Products | 1,068 out of 1,462 | 27th |
Industry group Drugs | 820 out of 1,156 | 29th |
Industry Pharmaceutical Preparations | 647 out of 890 | 27th |
Source: SEC filing on April 29, 2015.
Vetticaden's colleagues
We found two more compensation records of executives who worked with Santosh J. Vetticaden at Mast Therapeutics in 2013.